Antibiotic resistance in Haemophilus influenzae decreased, except for β-lactamase-negative amoxicillin-resistant isolates, in parallel with community antibiotic consumption in spain from 1997 to 2007

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 8, 2008, Pages 2760-2766

  García Cobos, Silvia ^a   Campos, José ^a,b   Cercenado, Emilia ^c   Román, Federico ^a   Lázaro, Edurne ^d   Pérez Vázquez, María ^a   De Abajo, Francisco ^d   Oteo, Jesús ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CSIC   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d Division de Farmacoepidemiologia y Farmacovigilancia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAMASE TEM 1; CEFACLOR; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; NALIDIXIC ACID; TELITHROMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENZYME SYNTHESIS; FTSI GENE; GENE; GENE MUTATION; GEOMETRY; HAEMOPHILUS INFLUENZAE TYPE A; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TIME SERIES ANALYSIS;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG UTILIZATION; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; SPAIN;

EID: 48749113948     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01674-07     Document Type: Article

References (28)

1. Campos, J., S. García-Tornel, and I. Sanfeliu. 1984. Susceptibility studies of multiply resistant Haemophilus influenzae isolated from pediatric patients and contacts. Antimicrob. Agents Chemother. 25:706-709.
2. Campos, J., M. Hernando, F. Román, M. Pérez- Vázquez, B. Aracil, J. Oteo, F. de Abajo, et al. 2004. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J. Clin. Microbiol. 42:524-529.
3. Campos, J., F. Román, M. Pérez-Vázquez, B. Aracil, J. Oteo, E. Cercenado, et al. 2003. Antibiotic resistance and clinical significance of Haemophilus influenzae type f. J. Antimicrob. Chemother. 52:961-966.
4. Campos, J., F. Román, M. Pérez-Vázquez, J. Oteo, B. Aracil, E. Cercenado, et al. 2003. Infections due to Haemophilus influenzae serotype E: microbiological, clinical, and epidemiological features. Clin. Infect. Dis. 37:841-845.
5. Campos, J., and J. A. Sáez-Nieto. 2001. gram-negative infections: Haemophilus and other clinically relevant gram-negative coccobacilli, p. 557 to 580. In N. Cimolai (ed.), Laboratory diagnosis of bacterial infections. Marcel Dekker, Inc., New York, NY.
6. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 17th ed. Approved standard M100-S17. CLSI, Wayne, PA.
7. Dabernat, H., C. Delmas, M. Seguy, R. Pelisser, G. Faucon, S. Bennamani, and C. Pasquier. 2002. Diversity of ß-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46:2208-2218.
8. Falla, T. J., D. W. Crook, L. N. Brophy, D. Maskell, J. S. Kroll, and E. R. Moxon. 1994. PCR for capsular typing of Haemophilus influenzae. J. Clin. Microbiol. 32:2382-2386.
9. Fleischmann, R. D., M. D. Adams, O. White, R. A. Clayton, E. F. Kirkness, A. R. Kerlavage, C. J. Bult, J. F. Tomb, B. A. Dougherty, J. M. Merrick, K. McKenney, G. Sutton, W. FitzHugh, C. Fields, J. D. Gocayne, J. Scott, R. Shirley, L. Liu, A. Glodek, J. M. Kelley, J. F. Weidman, C. A. Phillips, T. Spriggs, E. Hedblom, M. D. Cotton, T. R. Utterback, M. C. Hanna, D. T. Nguyen, D. M. Saudek, R. C. Brandon, L. D. Fine, J. L. Fritchman, J. L. Fuhrmann, N. S. M. Geoghagen, C. L. Gnehm, L. A. McDonald, K. V. Small, C. M. Fraser, H. O. Smith, and J. C. Venter. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512.
10. Fluit, A. C., A. Florijn, J. Verhoef, and D. Milatovic. 2005. Susceptibility of European β-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. J. Antimicrob. Chemother. 56:133-138.
11. García-Cobos, S., J. Campos, E. Lázaro, F. Román, E. Cercenado, C. García-Rey, M. Pérez-Vázquez, J. Oteo, and F. de Abajo. 2007. Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob. Agents Chemother. 51:2564-2573.
12. Goossens, H., M. Ferech, R. Vander Stichele, M. Elseviers, et al. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579-587.
13. Hasegawa, K., K. Yamamoto, N. Chiba, R. Kobayashi, K. Nagai, M. R. Jacobs, P. C. Appelbaum, K. Sunakawa, and K. Ubukata. 2003. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb. Drug Resist. 9:39-46.
14. Heilmann, K. P., C. L. Rice, A. L. Miller, N. J. Miller, S. E. Beekmann, M. A. Pfaller, S. S. Richter, and G. V. Doern. 2005. Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob. Agents Chemother. 49:2561-2564.
15. Hotomi, M., K. Fujihara, D. S. Billal, K. Suzuki, T. Nishimura, S. Baba, and N. Yamanaka. 2007. Genetic characteristics and clonal dissemination of β-lactamase non-producing ampicillin-resistant (BLNAR) Haemophilus influenzae isolated from the upper respiratory tract in Japan. Antimicrob. Agents Chemother. 51:3969-3976.
16. Jacobs, M. R., D. Felmingham, P. C. Appelbaum, R. N. Grüneberg, et al. 2003. The Alexander Project 1998-2000: susceptibility of pathogens isolates from community-acquired respiratory tract infection to commonly used antimicrobial agents. J. Antimicrob. Chemother. 52:229-246.
17. Jansen, W. T., A. Verel, M. Beitsma, J. Verhoef, and D. Milatovic. 2006. Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. J. Antimicrob. Chemother. 58:873-877.
18. Kim, I. S., C. S. Ki, S. Kim, W. S. Oh, K. R. Peck, J. H. Song, K. Lee, and N. Y. Lee. 2007. Diversity of ampicillin-resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae isolated in Korea. Antimicrob. Agents Chemother. 51:453-460.
19. Matic, V., B. Bozdogan, M. R. Jacobs, K. Ubukata, and P. C. Appelbaum. 2003. Contribution of β-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in β-lactamase- positive, amoxicillin/clavulanate-resistant Haemophilus influenzae. J. Antimicrob. Chemother. 52:1018-1021.
20. Molina, J. M., J. Cordoba, A. Monsoliu, N. Diosdado, and M. Gobernado. 2003. Haemophilus influenzae and β-lactam resistance: description of bla TEM gene deletion. Rev. Esp. Quimioter. 16:195-203. Spanish.
21. O'Callaghan, C. H., A. Morris, S. M. Kirby, and A. H. Shinger. 1972. Novel method for detection of β-lactamase by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:283-288.
22. Sanbongi, Y., T. Suzuki, Y. Osaki, N. Senju, T. Ida, and K. Ubukata. 2006. Molecular evolution of beta-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan. Antimicrob. Agents Chemother. 50:2487-2492.
23. Sutcliffe, J. G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75:3737-3741.
24. TEM genes and promoters in Haemophilus influenzae. J. Antimicrob. Chemother. 56:481-484.
25. TEM promoter variant. J. Antimicrob. Chemother. 58:183-185.
26. Ubukata, K. 2003. Problems associated with high prevalence of multidrug-resistant bacteria in patients with community-acquired infections. J. Infect. Chemother. 9:285-291.
27. Ubukata, K., Y. Shibasaki, K. Yamamoto, N. Chiba, K. Hasegawa, Y. Takeuchi, K. Sunakawa, M. Inoue, and M. Konno. 2001. Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 45:1693-1699.
28. World Health Organization. 2005. WHO Collaborating Centre for Drug Statistics Methodology: guidelines for ATC classification and DDD assignment. World Health Organization, Oslo, Norway.